COMMUNIQUÉS West-GlobeNewswire

PLx Pharma on Track for VAZALORE Regulatory Pathway
19/06/2019
HOUSTON, June 19, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]
Nabriva Therapeutics Submits Type A Meeting Request to FDA for Intravenous CONTEPO™ (fosfomycin) for injection
19/06/2019
DUBLIN, Ireland, June 19, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious [...]
Sorrento Therapeutics Updates Positive Results of Phase 1b Resiniferatoxin (RTX) in Knee Osteoarthritis Pain Trial
19/06/2019
Forty five patients were treated with escalating doses of RTX in the Phase 1b trial to date. Thirty seven patients received RTX and eight patients received saline (pooled as placebo group). Most adverse events [...]
Abeona Therapeutics reçoit la désignation « Fast Track » de la FDA pour la thérapie génique ABO‑202 AAV9 dans la maladie CLN1
19/06/2019
NEW YORK et CLEVELAND, 19 juin 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), chef de file entièrement intégré dans la thérapie génique et cellulaire, a annoncé aujourd'hui que la Food and Drug [...]
Fennec Announces Results of Annual Meeting
19/06/2019
RESEARCH TRIANGLE PARK, N.C., June 19, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14 [...]
MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal
19/06/2019
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) , a leader in specialized, research-driven cannabis extraction and cannabinoid [...]
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
19/06/2019
RANCHO CUCAMONGA, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) today announced that it has entered into a settlement agreement (the “Settlement Agreement”) with Momenta [...]
RAFARMA Adds Blockchain Tech to Cannabis Distribution
19/06/2019
Ljubljana, Slovenia, June 19, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc (OTC: RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of the leading developers of [...]
C-RAD announces resignation of board member
19/06/2019
C-RAD announces today that Peter Eidensjö has announced that he resigns from the Company's board of directors, effective June 19, 2019. "On behalf of our board of directors, I thank Peter for his valuable service and [...]
1,767 Orion Corporation A shares converted into B shares
19/06/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2019 at 9.30 EEST 1,767 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 1,767 A [...]
ObsEva Progressing Toward U.S. Phase 3 Trial for Nolasiban in IVF Following Recent FDA Meeting
19/06/2019
Geneva, Switzerland and Boston, MA – June 19, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock
19/06/2019
SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the pricing of [...]
Calithera Biosciences, Inc. Prices Public Offering of 12,500,000 shares of Common Stock
19/06/2019
SOUTH SAN FRANCISCO, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]
Vigil Health Solutions Reports Profitable Fiscal 2019
19/06/2019
VICTORIA, British Columbia, June 18, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-VEN: VGL) announces the results of operations for the fiscal year and the fourth quarter, ending March 31, 2019. [...]
Scholar Rock Announces Proposed Public Offering of Common Stock
18/06/2019
CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
Micron Solutions, Inc. Announces Real Estate Sale, Changes to its Board of Directors and Letter from NYSE American
18/06/2019
FITCHBURG, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
SELLAS Life Sciences Announces Closing of $15 Million Public Offering
18/06/2019
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) (“SELLAS” or the “Company”), a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapeutics [...]
Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome
18/06/2019
SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes of [...]
Flexion Therapeutics to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
18/06/2019
BURLINGTON, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led [...]

Pages